DESIGN, FORMULATION, AND IN-VITRO EVALUATION OF IMMEDIATE RELEASE TABLET OF ETORICOXIB USING QUALITY BY DESIGN (QbD) APPROACH

QUALITY BY DESIGN (QbD) APPROACH FOR ETORICOXIB

  • Anchal Sharma Shiva College of Pharmacy, Bilaspur, Himachal Pradesh, India
  • Bhupendra Singh Department of Pharmaceutical Sciences, Teerthankar Mahaveer University, Moradabad, U.P., India
  • Amit Chaudhary School of Pharmacy, Abhilashi University, Chailchowk, Mandi H.P., India
  • Geetanjali Saini Department of Pharmaceutical Sciences, Teerthankar Mahaveer University, Moradabad, U.P., India
  • Manish Vyas Department of Pharmaceutical Sciences, Lovely Professional Univerity, Phagwara, Punjab, India

Abstract

Introduction: The current research aimed to formulate and evaluate the immediate-release tablet of etoricoxib. Etoricoxib belongs to BCS class II drugs; hence the solubility was enhanced using different techniques, thus achieving the dissolution of the drug. The formulation with maximum solubility enhancement was selected as the final formulation for the preparation of immediate-release tablets. Material and Methods: These tablets were prepared using the wet granulation technique. Sodium starch glycolate was used as a super disintegrant, microcrystalline cellulose was used as a binder, and sodium bicarbonate was used as effervescent material for the preparation of an immediate-release tablet. Different trial batches were prepared and the formulations were optimized using design expert software. The optimized formulation was prepared and evaluated for different post-compression parameters. Results and Discussion: The disintegration time was found to be 2 minutes 16 seconds and the percent cumulative drug release was found to be 90.30%. The pharmacokinetic behavior of the drug was studied and first-order kinetics was found to be the best fit model for immediate-release tablets. The accelerated stability study for the immediate-release tablet was carried out at 40℃ ±75% RH and different parameters were evaluated and were found within specified limits. Conclusion: Thus immediate release tablets of etoricoxib were found to be a promising candidate for the treatment of acute pain or arthritis.

Keywords: Solubility, Optimization, Pharmacokinetic Study, Super Disintegrants, Stability Study

Downloads

Download data is not yet available.
Statistics
466 Views | 532 Downloads
How to Cite
Sharma, A., B. Singh, A. Chaudhary, G. Saini, and M. Vyas. “DESIGN, FORMULATION, AND IN-VITRO EVALUATION OF IMMEDIATE RELEASE TABLET OF ETORICOXIB USING QUALITY BY DESIGN (QbD) APPROACH”. Journal of Applied Pharmaceutical Sciences and Research, Vol. 6, no. 1, June 2023, pp. 25-33, doi:10.31069/japsr.v6i1.04.
Section
Research Articles